Sinonasal malignancies: histopathological entities, regional involvement and long-term outcome

[1]  L. Anschuetz,et al.  Morbidity and Oncological Outcome After Curative Treatment in Sinonasal Squamous Cell Carcinoma. , 2022, Ear, nose, & throat journal.

[2]  E. Moore,et al.  Nodal and distant metastases in sinonasal mucosal melanoma: A population‐based analysis , 2020, The Laryngoscope.

[3]  A. Devaiah,et al.  Education and insurance status: Impact on treatment and survival of sinonasal cancer patients , 2020, The Laryngoscope.

[4]  A. Dietz,et al.  Best Practice in Surgical Treatment of Malignant Head and Neck Tumors , 2020, Frontiers in Oncology.

[5]  E. Kuan,et al.  Treatment modalities in sinonasal mucosal melanoma: A national cancer database analysis , 2020, The Laryngoscope.

[6]  N. Saba,et al.  Multimodal Therapy for Sinonasal Malignancies: Updates and Review of Current Treatment , 2020, Current Treatment Options in Oncology.

[7]  G. Veronesi,et al.  The role of a post therapeutic surveillance program for sinonasal malignancies: Analysis of 417 patients , 2019, Head & neck.

[8]  B. Judson,et al.  Margins in Sinonasal Squamous Cell Carcinoma: Predictors, Outcomes, and the Endoscopic Approach , 2019, The Laryngoscope.

[9]  M. S. St John,et al.  Should an elective neck dissection be performed for maxillary sinus squamous cell carcinoma? , 2019, The Laryngoscope.

[10]  P Reichardt,et al.  Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  S. Sleijfer,et al.  Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  K. Zaoui,et al.  Quality of life after nasal cancer resection - surgical versus prosthetic rehabilitation. , 2018, Rhinology.

[13]  A. Ribas,et al.  Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006 , 2018, British Journal of Cancer.

[14]  K. Zaoui,et al.  Primary surgical treatment of nasal vestibule cancer - therapeutic outcome and reconstructive strategies. , 2018, Rhinology.

[15]  J. Eloy,et al.  The role of elective neck dissection in the treatment of maxillary sinus squamous cell carcinoma , 2018, The Laryngoscope.

[16]  E. Moore,et al.  Rates and Locations of Regional Metastases in Sinonasal Malignancies: The Mayo Clinic Experience , 2017, Journal of Neurological Surgery Part B: Skull Base.

[17]  S. Karam,et al.  A comprehensive comparative analysis of treatment modalities for sinonasal malignancies , 2017, Cancer.

[18]  Eva Ardanaz,et al.  Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. , 2017, The Lancet. Oncology.

[19]  K. Savage,et al.  Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  G. Kayser,et al.  Squamous cell cancer of the nasal cavity: New insights and implications for diagnosis and treatment , 2016, Head & neck.

[21]  S. Abu-Ghanem,et al.  Elective neck irradiation versus observation in squamous cell carcinoma of the maxillary sinus with N0 neck: A meta‐analysis and review of the literature , 2015, Head & neck.

[22]  J. Eloy,et al.  Sinonasal malignancies: A population‐based analysis of site‐specific incidence and survival , 2015, The Laryngoscope.

[23]  T. Mom,et al.  Mucosal melanoma of the nasal cavity and paranasal sinuses. , 2014, European annals of otorhinolaryngology, head and neck diseases.

[24]  R. Sullivan,et al.  Ipilimumab for patients with advanced mucosal melanoma. , 2013, The oncologist.

[25]  A. Aupérin,et al.  Nodal recurrence of sinonasal cancer: does the risk of cervical relapse justify a prophylactic neck treatment? , 2013, Oral oncology.

[26]  M. Caversaccio,et al.  Therapy options and long-term results of sinonasal malignancies. , 2012, Oral oncology.

[27]  G. Gatta,et al.  Rare cancers of the head and neck area in Europe. , 2012, European journal of cancer.

[28]  J. Langendijk,et al.  Lymph node metastasis in nasal vestibule cancer: A review , 2011, Head & neck.

[29]  M. Caversaccio,et al.  Esthesioneuroblastoma: irradiation alone and surgery alone are not enough. , 2002, International journal of radiation oncology, biology, physics.

[30]  S. Lang,et al.  Regional recurrence in a case series of patients with carcinoma of the nasal cavity - therapeutic implications. , 2017, Rhinology.

[31]  Gemma Gatta,et al.  The burden of rare cancers in Europe. , 2010, Advances in experimental medicine and biology.

[32]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..